IDEXX Laboratories Inc
IDXX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000874716
In the last 90 days, IDEXX Laboratories Inc insiders filed 0 open-market purchases and 1 sale; 1,306 institutions reported holding it in 13F filings for Q2 2026, worth $39.1B in total; 3 superinvestors hold it, including Fundsmith and Weitz Investment Management.
Q1 2022 vs. Q4 2021
How the institutions holding IDEXX Laboratories Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 1,110 | 10 | 1,036 | −64 |
| Shares | 71.8M | 38.5K | 72.8M | +1.11M (+1.6%) |
| Value | $47.1B | $25.3M | $39.7B | −$7.34B (−15.6%) |
10 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (78)
Institutions that held IDEXX Laboratories Inc at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (142)
Institutions that held IDEXX Laboratories Inc at the end of Q4 2021 and filed for Q1 2022 without it.
Showing the largest 100 of 142 by value.
Not filed for Q1 2022 yet (10)
Institutions that held IDEXX Laboratories Inc at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Andra AP-fonden | 29,400 | $19.4M |
| MD Financial Management Inc. | 4,948 | $3.26M |
| NEXT Financial Group, Inc | 2,095 | $1.38M |
| Legg Mason Asset Management (Japan) Co., Ltd. | 1,291 | $850.0K |
| First Midwest Bank Trust Division | 325 | $214.0K |
| Reilly Financial Advisors, LLC | 216 | $142.0K |
| Harbour Investments, Inc. | 81 | $53.0K |
| Carroll Financial Associates, Inc. | 68 | $44.0K |
| Bell Investment Advisors, Inc | 56 | $37.0K |
| Castle Financial & Retirement Planning Associates, Inc. | 8 | $4.00K |